TABLE 4.
Five-years follow up survival data.
| Diabetes treatment | Age (year) x (SD) | Alive n (%) | Dead n (%) | OR | 95% CI | P-value |
|---|---|---|---|---|---|---|
| Metformin (n = 41) | 68 (7) | 40 (97.6) | 1 (2.4) | 9.4 | (1.32–117.4) | 0.041 |
| Non Met drugs (n = 21) | 70 (7.4) | 17 (81) | 4 (19) | |||
| Metformin (n = 41) | 68 (7) | 40 (97.6) | 1 (2.4) | 1.37 | (0.17–16.5) | 0.9 |
| Healthy (n = 151) | 63 (5.8) | 146 (96.7) | 5 (3.3) | |||
| Metformin (n = 41) | 68 (7) | 40 (97.6) | 1 (2.4) | 1.8 | (0.29–19.5) | 0.9 |
| Non-DM (n = 370) | 69 (7.8) | 354 (95.7) | 16 (4.3) | |||
| Metformin (n = 41) | 68 (7) | 40 (97.6) | 1 (2.4) | 2.6 | (0.37–31.7) | 0.662 |
| Pre DM (n = 81) | 68 (7.8) | 76 (93.8) | 5 (6.2) | |||
| Non-MET Drugs (n = 21) | 70 (7.4) | 17 (81) | 4 (19) | 0.14 | (0.04 – 0.52) | 0.014 |
| Healthy (n = 151) | 63 (5.8) | 146 (96.7) | 5 (3.3) | |||
| Non-MET Drugs (n = 21) | 70 (7.4) | 17 (81) | 4 (19) | 0.19 | (0.06–0.57) | 0.017 |
| Non DM (n = 370) | 69 (7.8) | 354 (95.7) | 16 (4.3) | |||
| Non-MET Drugs (n = 21) | 70 (7.4) | 17 (81) | 4 (19) | 0.28 | (0.07–1) | 0.083 |
| Pre DM (n = 81) | 68 (7.8) | 76 (93.8) | 5 (6.2) |